Data on the number of cases for these diseases from the pre-vaccine era is hard to come by, and even the case counts are ...

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine ...

US-based PharmaJet, a company dedicated to enhancing injectable performance through needle-free injection technology, has ...

Currently, IPV is relatively expensive to produce because it requires high levels of bio-containment to minimise the risk of leaks of live poliovirus, which could result in outbreaks. VLPs are ...

Uttarakhand High Court acquitted a polio-affected man convicted of rape and ordered the state government to compensate him ...

Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...

Scientists have developed a vaccine using virus-like particles (VLPs), which mimic the poliovirus but do not contain any ...

A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).

On an August morning in 1949, when I was six, I got out of bed and collapsed on the floor. By evening, I was paralyzed from the neck down and in an iron lung. I spent the next five months in a polio ...

Grifols has shared positive results from its clinical trial evaluating the efficacy and safety of intravenous immunoglobulin to treat patients with PPS.